Endoscopic Retrograde Cholangiopancreatography Market/ERCP Market

During The Forecast Period, Olympus Corporation (Japan), Fujifilm Holdings Corporation (Japan), and HOYA Corporation (Japan), and Boston Scientific Corporation (US) are the Leading Players in the Global Endoscopic Retrograde Cholangiopancreatography Market

The global endoscopic retrograde cholangiopancreatography market is projected to reach USD 2.0 billion by 2026 from USD 1.3 billion in 2021, at a CAGR of 9.6% during the forecast period. The growth of this market is majorly attributed to factors such as the rising incidence of cancer, increasing investments by governments and healthcare organizations to improve endoscopy research, growing focus on investments by hospitals for advanced endoscopy instruments, and the increasing preference for minimally invasive surgeries.

Key players in the ERCP market include Olympus Corporation (Japan), CONMED Corporation (US), Fujifilm Holdings Corporation (Japan), HOYA Corporation (Japan), KARL STORZ SE & Co. KG (Germany), Ambu A/S (Denmark), Boston Scientific Corporation (US), Johnson & Johnson (US), Medtronic, PLC (Ireland), Cook Medical (US), and B. Braun Melsungen AG (Germany).

To know about the assumptions considered for the study download the pdf brochure

Olympus Corporation (Japan): Olympus is a leading player in the endoscopic retrograde cholangiopancreatography market. The company uses alliances and acquisitions to get a strong ERCP market. For instance, in January 2021, the company entered a five-year contract to jointly develop endoscopic ultrasound systems (EUS) with Hitachi Ltd. (Japan). Similarly, in January 2021, the company acquired Quest Innovations B.V. (Netherlands), which enabled Olympus to strengthen its surgical endoscopy capabilities and incorporate Quest’s advanced FIS capabilities into its comprehensive medical imaging portfolio. The company operates in around 40 countries across the Americas, Africa, Eastern Europe, the Middle East, Asia, and Oceania.

Fujifilm Holdings Corporation (Japan): Fujifilm is one of the key players in the endoscopic retrograde cholangiopancreatography market. The company uses product launches, acquisitions, and partnerships to strengthen its position in the market. For instance, in July 2020, Fujifilm launched ELUXEO Surgical Visualization System, which enables surgeons to visualize while performing both flexible and rigid endoscopy from a single tower. Additionally, in March 2021, the company acquired Hitachi, Ltd.’s Diagnostic Imaging-related Business (Japan), which enabled Fujifilm to expand its Healthcare business further. The company has a vast geographic reach across North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa.

HOYA Corporation (Japan): HOYA Corporation is one of the leading players in the ERCP Market. The company resorts to product launches, acquisitions, and joint ventures to hold its position in the market. For instance, in May 2021, PENTAX Medical (Japan), a subsidiary of HOYA Corporation, entered a joint venture with Vedkang Medical Science and Technology Co., Ltd. (China) to develop single-use therapeutic products in the field of flexible medical endoscopy. In addition, in May 2021, the company launched PENTAX Medical ONE Pulmo Bronchoscope. The company has a widespread presence worldwide, spanning North America, Europe, Asia, and Oceania.

Boston Scientific Corporation: Boston Scientific Corporation develops, manufactures, and markets medical devices for several interventional medical specialties (including endoscopy). The company has a strong geographic presence in the US, the Asia Pacific, and other main markets in Europe. Bostin Scientific’s products are distributed worldwide through customer service centers in the US, the Netherlands, and Japan. There was a steady growth in the R&D expenditure from USD 920 million in 2016 to USD 1,143 million in 2020.

Related Reports:

Endoscopic Retrograde Cholangiopancreatography/ERCP Market by Product (Upper GI endoscopes, Stent, Balloons, Catheters, Baskets), Procedure (Biliary Sphincterotomy & Stenting, Pancreatic Sphincterotomy), End User (Hospitals) - Global Forecast to 2026

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Report Code
MD 8059
RI Published ON
3/11/2022
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Endoscopic Retrograde Cholangiopancreatography Market/ERCP Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2022 MarketsandMarkets Research Private Ltd. All rights reserved